Baxter Bros Inc Biogen Inc. Transaction History

Baxter Bros Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $1.08 Million - $1.73 Million	-4,170 Closed	0 $0
Q1 2021 Apr 23, 2021	SELL	$242.95 - $284.63 $408,156 - $478,178	-1,680 Reduced 28.72%	4,170 $1.17 Million
Q4 2020 Jan 25, 2021	SELL	$236.26 - $355.63 $49,614 - $74,682	-210 Reduced 3.47%	5,850 $1.43 Million
Q3 2020 Nov 05, 2020	BUY	$264.77 - $305.71 $260,268 - $300,512	983 Added 19.36%	6,060 $1.72 Million
Q2 2020 Jul 31, 2020	SELL	$258.66 - $342.55 $35,695 - $47,271	-138 Reduced 2.65%	5,077 $1.36 Million
Q1 2020 Apr 17, 2020	BUY	$268.85 - $341.04 $365,904 - $464,155	1,361 Added 35.31%	5,215 $1.65 Million
Q4 2019 Jan 10, 2020	BUY	$220.06 - $304.07 $848,111 - $1.17 Million	3,854 New	3,854 $1.14 Million
Q4 2019 Jan 09, 2020	SELL	$220.06 - $304.07 $207,736 - $287,042	-944 Closed	0 $0
Q3 2019 Oct 21, 2019	SELL	$217.44 - $243.88 $10,872 - $12,194	-50 Reduced 5.03%	944 $220,000
Q2 2019 Jul 29, 2019	SELL	$219.29 - $241.72 $31,797 - $35,049	-145 Reduced 12.73%	994 $232,000
Q1 2019 Apr 22, 2019	BUY	$216.71 - $338.96 $23,838 - $37,285	110 Added 10.69%	1,139 $269,000
Q4 2018 Jan 22, 2019	BUY	$278.5 - $352.75 $15,317 - $19,401	55 Added 5.65%	1,029 $310,000
Q3 2018 Oct 11, 2018	SELL	$293.51 - $383.83 $8,218 - $10,747	-28 Reduced 2.79%	974 $344,000
Q2 2018 Jul 17, 2018	BUY	$257.52 - $306.91 $7,210 - $8,593	28 Added 2.87%	1,002 $291,000
Q1 2018 May 16, 2018	SELL	$260.13 - $367.91 $20,290 - $28,696	-78 Reduced 7.41%	974 $267,000
Q3 2017 Oct 16, 2017	BUY	$281.15 - $329.69 $295,769 - $346,833	1,052	1,052 $329,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

Stay updated on Baxter Bros Inc with notifications on news.